193 related articles for article (PubMed ID: 22427514)
1. Disruption of group IVA cytosolic phospholipase A(2) attenuates myocardial ischemia-reperfusion injury partly through inhibition of TNF-α-mediated pathway.
Saito Y; Watanabe K; Fujioka D; Nakamura T; Obata JE; Kawabata K; Watanabe Y; Mishina H; Tamaru S; Kita Y; Shimizu T; Kugiyama K
Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H2018-30. PubMed ID: 22427514
[TBL] [Abstract][Full Text] [Related]
2. Group V secretory phospholipase A2 plays a pathogenic role in myocardial ischaemia-reperfusion injury.
Yano T; Fujioka D; Saito Y; Kobayashi T; Nakamura T; Obata JE; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Tamaru S; Kugiyama K
Cardiovasc Res; 2011 May; 90(2):335-43. PubMed ID: 21169294
[TBL] [Abstract][Full Text] [Related]
3. TNF-α antagonism ameliorates myocardial ischemia-reperfusion injury in mice by upregulating adiponectin.
Gao C; Liu Y; Yu Q; Yang Q; Li B; Sun L; Yan W; Cai X; Gao E; Xiong L; Wang H; Tao L
Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1583-91. PubMed ID: 25888509
[TBL] [Abstract][Full Text] [Related]
4. A single intravenous sTNFR-Fc administration at the time of reperfusion limits infarct size--implications in reperfusion strategies in man.
Toufektsian MC; Robbez-Masson V; Sanou D; Jouan MG; Ormezzano O; de Leiris J; Boucher F
Cardiovasc Drugs Ther; 2008 Dec; 22(6):437-42. PubMed ID: 18690528
[TBL] [Abstract][Full Text] [Related]
5. Cytosolic phospholipase A(2)α protects against ischemia/reperfusion injury in the heart.
Kerkelä R; Boucher M; Zaka R; Gao E; Harris D; Piuhola J; Song J; Serpi R; Woulfe KC; Cheung JY; O'Leary E; Bonventre JV; Force T
Clin Transl Sci; 2011 Aug; 4(4):236-42. PubMed ID: 21884509
[TBL] [Abstract][Full Text] [Related]
6. TNF-α inhibitor protects against myocardial ischemia/reperfusion injury via Notch1-mediated suppression of oxidative/nitrative stress.
Pei H; Song X; Peng C; Tan Y; Li Y; Li X; Ma S; Wang Q; Huang R; Yang D; Li D; Gao E; Yang Y
Free Radic Biol Med; 2015 May; 82():114-21. PubMed ID: 25680284
[TBL] [Abstract][Full Text] [Related]
7. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
[TBL] [Abstract][Full Text] [Related]
8. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
[TBL] [Abstract][Full Text] [Related]
9. Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury.
Chen C; Feng Y; Zou L; Wang L; Chen HH; Cai JY; Xu JM; Sosnovik DE; Chao W
J Am Heart Assoc; 2014 Jan; 3(1):e000683. PubMed ID: 24390148
[TBL] [Abstract][Full Text] [Related]
10. IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury.
Moss NC; Stansfield WE; Willis MS; Tang RH; Selzman CH
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2248-53. PubMed ID: 17675566
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner.
Birnbaum Y; Long B; Qian J; Perez-Polo JR; Ye Y
Basic Res Cardiol; 2011 May; 106(3):431-46. PubMed ID: 21360043
[TBL] [Abstract][Full Text] [Related]
12. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of TNF-alpha reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog.
Gu Q; Yang XP; Bonde P; DiPaula A; Fox-Talbot K; Becker LC
J Cardiovasc Pharmacol; 2006 Dec; 48(6):320-8. PubMed ID: 17204912
[TBL] [Abstract][Full Text] [Related]
14. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
[TBL] [Abstract][Full Text] [Related]
15. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor receptor 1 signaling resistance in the female myocardium during ischemia.
Wang M; Tsai BM; Crisostomo PR; Meldrum DR
Circulation; 2006 Jul; 114(1 Suppl):I282-9. PubMed ID: 16820587
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 3 plays a role in myocardial infarction and ischemia/reperfusion injury.
Lu C; Ren D; Wang X; Ha T; Liu L; Lee EJ; Hu J; Kalbfleisch J; Gao X; Kao R; Williams D; Li C
Biochim Biophys Acta; 2014 Jan; 1842(1):22-31. PubMed ID: 24140513
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cytosolic phospholipase A(2) alpha protects against focal ischemic brain damage in mice.
Zhang J; Barasch N; Li RC; Sapirstein A
Brain Res; 2012 Aug; 1471():129-37. PubMed ID: 22819928
[TBL] [Abstract][Full Text] [Related]
19. Etanercept attenuates myocardial ischemia/reperfusion injury by decreasing inflammation and oxidative stress.
Yang M; Chen J; Zhao J; Meng M
PLoS One; 2014; 9(9):e108024. PubMed ID: 25260027
[TBL] [Abstract][Full Text] [Related]
20. Atypical lambda/iota PKC conveys 5-lipoxygenase/leukotriene B4-mediated cross-talk between phospholipase A2s regulating NF-kappa B activation in response to tumor necrosis factor-alpha and interleukin-1beta.
Anthonsen MW; Andersen S; Solhaug A; Johansen B
J Biol Chem; 2001 Sep; 276(38):35344-51. PubMed ID: 11445585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
